Please provide your email address to receive an email when new articles are posted on . Use of an electronic patient-reported outcome-based program did not significantly reduce ED or inpatient visits ...
Bimekizumab is associated with significant improvements through 3 years across various patient-reported outcomes in those ...
A study published in Rheumatology & Autoimmunity challenges the assumption that achieving clinical remission in rheumatoid ...
An expert discusses how rilzabrutinib uniquely improves quality-of-life metrics, including fatigue and women’s health domains, which previous immune thrombocytopenia (ITP) therapies failed to address ...
SAN DIEGO, June 2, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced new data from the Phase 4 KINECT-PROTM open-label study demonstrating robust and sustained ...
The SISAQOL-IMI consortium, co-led by the European Organization for Research and Treatment of Cancer (EORTC) and Boehringer Ingelheim (BI), has published a paper in The Lancet Oncology outlining how ...
Forbes contributors publish independent expert analyses and insights. Michael L. Millenson writes about healthcare as a skeptical optimist. An unusual study gives a new twist to the idea of ...
Video-based genetic counseling to reduce physician workload and enhance consulter understanding: A prospective randomized clinical trial. This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...
We comment on Dr. Dai et al.’s well-designed study in Journal of Clinical Oncology (1). This article reports the results of a randomized clinical trial comparing standard postoperative care with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results